8 million OTC covid-19 test kits
Ended Definitive Contract Awarded Last action
- Contract number
- W58P0522C0013
- Awardee
-
Maxim Biomedical, Inc. UEI YV7LJS28ERK8
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $54,640,000
Award facts
- Opportunity
-
- Rapid COVID-19 Antigen Test Kits Special Notice · W58P0522R0003 · Posted Dec 22, 2021
- Contract value 100% obligated
- $54,640,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Chambersburg, PA 17201, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $54,640,000 |
About this award
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $54.64 million firm fixed price definitive contract to Maxim Biomedical, Inc. to deliver 8 million over-the-counter COVID-19 antigen test kits. The tests will be produced at Maxim's Chambersburg, Pennsylvania facility between February 18, 2022 and July 15, 2022. The solicitation sought information on the availability of FDA Emergency Use Authorized or 510(k) cleared rapid antigen tests to support Department of Defense and Department of Health and Human Services personnel testing needs through April 2022. No subcontractors or set aside designations were identified. This contract supports the Department of Defense's ongoing efforts to provide COVID-19 diagnostic capabilities under the Joint PEO Chemical and Biological Defense program.
Quick answers
Who was awarded contract W58P0522C0013?
W58P0522C0013 was awarded to Maxim Biomedical, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on February 18, 2022.
How much is contract W58P0522C0013 worth?
The government has obligated $54,640,000 on W58P0522C0013.
Which agency awarded contract W58P0522C0013?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W58P0522C0013, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W58P0522C0013 competed?
The extent of competition for W58P0522C0013 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award